CLPT ClearPoint Neuro, Inc.
USHealthcareAs of 2026-07-10 16:00
Why CLPT matters now
ClearPoint Neuro, Inc. (CLPT) is a US stock in Healthcare. The latest InvestLog snapshot shows $17.50 with -2.13% on the session and $524.8M in market capitalization; recent performance reads 1-month +59.09% and YTD +29.90%.
The latest financial table shown here is Q1 2026, with revenue of $12.1M, net income of $-9.6M, and EPS of $-0.32. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -5.0%.
The latest indexable market news headline is "ClearPoint Neuro: AMT-130's FDA Reversal Revives The Bull Case" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Buy with a median target of $16.00; recent insider activity includes Richards Timothy T. filing M-Exempt. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
27.87
P/S
13.12
EV/EBITDA
-23.71
DCF Value
$-11.99
FCF Yield
-5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.8%
Operating Margin
-65.2%
Net Margin
-71.6%
ROE
-141.0%
ROA
-31.1%
ROIC
-31.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $12.1M | $-9.6M | $-0.32 |
| Q4 2025 | $10.4M | $-7.8M | $-0.27 |
| FY 2025 | $37.0M | $-25.5M | $-0.90 |
| Q3 2025 | $8.9M | $-5.9M | $-0.21 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$16.00
Target (Median)
$16.00
Target Range
$16.00 - $16.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.31
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.